Angiomics Inc

Angiomics Inc, based in Louisville, KY, is a pioneering company that specializes in vascularizing tissue for better biology outcomes in 3D tissue and organoid assays. Their patented human vascularization platform, Angiomics Microvessels, utilizes a whole microvessel harvesting process from human adipose tissue to create more native-like tissue environments. These isolated microvessels promote stable vascularization and parenchyma function, resulting in improved tissue function and models that mimic tissue and blood exchange as it occurs in the body.

With over 50 peer-reviewed publications since 1996, Angiomics Microvessels have been successfully researched and applied in various fields such as angiogenesis dynamics, tissue vascularization, and graft implant vascularization. The company's unique approach allows for the recapitulation of angiogenesis within a wide variety of 3D culture environments, making it a valuable tool for repairing tissue, modeling diseases, and conducting angiogenesis assays. Backed by 30 years of tissue vascularization expertise and support, Angiomics Inc is at the forefront of advancing the field of vascularized tissue.

Generated from the website